OncoSec Reports Preliminary Data from KEYNOTE-695 Phase 2b Registration-Directed Clinical Trial of TAVO(TM) in Combination with KEYTRUDA® for Metastatic Melanoma at Society for Immunotherapy of Cancer's 33rd Annual Meeting
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.